Bavarian Nordic Raises 2026 Guidance After Additional U.S. Vaccine Order
12/5 08:12
(RTTNews) - Bavarian Nordic A/S (BVNKF, BAVA.CO), a vaccine company, announced that the U.S. Biomedical Advanced Research and Development Authority (BARDA) has exercised option worth $97 million in the current contract to supply freeze-dried doses of its JYNNEOS smallpox vaccine....
